Sign in
Taking people in United StatesNo phase

Cerebral Physiology of NOWS

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Status
Recruiting
People taking part
46 people, planned
Started
11 Aug 2026
Expected to end
Aug 2027
Type of study
Interventional, 3 groups
Treatments tested
  • FD-NIRS and DCS
Record updated
19 August 2026

Who can take part

Age
Up to 1 day
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Infants with prenatal opioid exposure:
  • Term born or near-term born (> 36w) infants
  • Birth weight > 2 Kg
  • History of prenatal opioid exposure; Control infants:
  • Term born or near-term born (> 36w) infants
  • Birth weight > 2 Kg; Mothers of infants with prenatal opioid exposure:
  • greater or equal to 19 years of age
  • Use of opioid substances during pregnancy - Defined as pregnant women who 1) are clinically diagnosed as having an opioid use disorder and are on methadone or buprenorphine maintenance program or 2) have a urine drug test positive for prescribed or illicit opioids; Mothers of control infants:
  • greater than or equal to 19 years of age

Who cannot take part

  • Any major congenital malformations or genetic syndromes
  • Any major congenital malformations or genetic syndromes
  • Any history of prenatal opioid exposure; Mothers of infants with prenatal opioid exposure:
  • Major maternal illness during pregnancy or delivery that could impact infant cerebral perfusion as deemed by the study investigators (e.g. uterine rupture or preeclampsia); Mothers of control infants:
  • Major maternal illness during pregnancy or delivery that could impact infant cerebral perfusion as deemed by the study investigators (e.g. uterine rupture or preeclampsia)
  • Infants with prenatal opioid exposure:
  • APGAR score at 5 min < 7
  • Need for positive pressure ventilation in the delivery room; Control infants:
  • APGAR score at 5 min < 7
  • Need for positive pressure ventilation in the delivery room
  • Tobacco, SSRI or any opioid use during pregnancy

Where in United States

  • Indiana University/Riley Hospital for ChildrenIndianapolis, United StatesContact: Anna ThomasTaking people

About the trial

What the trial wants to find out

This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.

The 3 groups in the trial

  • Prenatal opioid exposure (POE)Treatment being tested

    A total of 20 newborns with prenatal opioid exposure will have daily bedside FD-NIRS/DCS measurements of cerebral oxygen saturation (SO₂), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO₂).

    Treatment: FD-NIRS and DCS

  • Healthy controlTreatment being tested

    A total of 20 healthy age-matched newborns will have daily bedside FD-NIRS/DCS measurements of cerebral oxygen saturation (SO₂), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO₂).

    Treatment: FD-NIRS and DCS

  • Pharmacologic TreatmentTreatment being tested

    A group of 6 newborns with POE who are treated pharmacologically for severe neonatal opioid withdrawal syndrome will have daily bedside FD-NIRS/DCS measurements of cerebral oxygen saturation (SO₂), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO₂).

    Treatment: FD-NIRS and DCS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Detection of Neonatal Opioid Withdrawal Syndrome Using a Novel Cerebral Monitor.
Record updated
19 August 2026